{"webUser":null}
Audioboom logo
{"flashNotices":[]}
Podcast logo
Listen & subscribe
Targeted Talks is a podcast series featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed for today's oncology professionals.
www.targetedonc.com/

Targeted Talks

Targeted Oncology
Medicine
90 episodes
S7 Ep19: AI in Oncology: Managing Information Overload for Trainees and Patients
In part 2 of this conversation, oncologists discuss how they help both patients and trainees navigate an overwhelming volume of medical information. The speakers describe encouraging patients to consult reliable resources like NCCN's patient site rather than turning solely to AI chatbots, while also acknowledging patients will inevitably seek outside information and clarification from family. ...
16m • Jul 15
16m
S7 Ep18: Drowning in Data: How Oncologists Are Coping with Information Overload in the AI Era
In this episode of Treating Together, host Dr Pallav Mehta sits down with Dr Kurt Demel and Dr Yan Ji, 2 community-based medical oncologists practicing in the Twin Cities, to tackle a problem every oncologist feels but few have named clearly: information overload. The conversation opens with a deceptively simple question: When does learning become overload? The group traces the line from the g...
21m • Jul 01
21m
S7 Ep17: Navigating the 505(b)(2) Pathway: Operational, Clinical, and Economic Strategies for Oncology Practices
In this episode, managing editor Sabrina Serani sits down with 3 experts at the intersection of oncology pharmacy, health informatics, and drug distribution to unpack the 505(b)(2) regulatory pathway and what it means for cancer centers navigating today's complex drug landscape. Guests: Jessica White, PharmD, Vice President, Specialty Programs & Portfolio Management at McKesson Derek Burns​, ...
22m • Jun 17
22m
S7 Ep16: ASCO 2026 Preview: Late-Breaking Abstracts Poised to Reshape the Treatment Landscape
Ahead of the 2026 ASCO Annual Meeting, Sabrina Serani, managing editor of Targeted Oncology, previews the late-breaking abstracts most likely to influence clinical practice across breast, colorectal, prostate, and lung cancer, as well as in metastatic uveal melanoma, a disease that has gone without an effective systemic therapy for decades. From VIKTORIA-1 in PIK3CA-mutant metastatic breast can...
11m • May 20
11m
S7 Ep15: Pediatric Blood Cancers: Building Better Outcomes Through Bold Science
In this episode of the Treating Together podcast, host Pallav Mehta, MD, medical oncologist at MD Anderson Cancer Center at Cooper University Health Care and medical director of Reimagine Care, speaks with E. Anders (Andy) Kolb, MD, president and chief executive officer of Blood Cancer United (formerly The Leukemia & Lymphoma Society; LLS). Together, they unpack the major forces shaping change ...
29m • May 06
29m
S7 Ep14: Choosing Wisely in CLL: A Deep Dive Into Frontline Treatment
In this episode of Treating Together, host Marc Braunstein, MD, PhD, associate professor of medicine at the NYU Perlmutter Cancer Center, sits down with Adam Kittai, MD, associate professor and director of the CLL and Lymphoma programs at NYU Perlmutter Cancer Center, for a deep dive into the rapidly evolving frontline treatment landscape in chronic lymphocytic leukemia (CLL). As chemotherapy c...
33m • Apr 15
33m
S7 Ep13: Leveraging AI, Social Media, and Virtual Care in the Information Age
In this episode of Targeted Oncology’s Treating Together podcast, Dr Pallav Mehta sits down with Dr Sanjay Juneja, aka The Onc Doc, a medical oncologist known for his social media presence and his work in medical informatics. The duo explores how the landscape of cancer care is shifting from a "paucity of information" to a challenge of "information overload," and how technology can bridge the g...
43m • Apr 01
43m
S7 Ep12: Beyond Monotherapy: Mechanisms and Combination Strategies in NPM1-Mutant Acute Myeloid Leukemia
41m • Mar 27
41m
S7 Ep11: Treating Together: Navigating Treatment Decisions in Relapsed NPM1-Mutant AML: Practical Insights for Clinical Care
Dr. Gabriel Mannis from Stanford University and Dr. Gail Roboz from Weill Cornell Medicine discussed the evolving treatment landscape for relapsed/refractory NPM1-mutant acute myeloid leukemia (AML) in this Targeted Oncology podcast. The conversation highlighted the dramatic transformation of relapsed/refractory AML management from a space where "drugs went to die" to one with multiple targeted...
41m • Mar 27
41m
S7 Ep10: Beyond the Hospital Walls: Expanding Access to Complex Cancer Therapies
In this episode of the Treating Together podcast, host Dr Pallav Mehta, medical oncologist at MD Anderson Cancer Center at Cooper, assistant professor of medicine at Cooper Medical School, and medical director of Reimagine Care, sits down with Jorge Garcia, PharmD, founder of Patagonia Healthcare, for an in-depth conversation about the rapidly evolving landscape of advanced cancer therapies, fr...
41m • Mar 25
41m
S7 Ep9: Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC
In this minisode, we break down the latest update to ASCO's living guideline for stage IV non–small cell lung cancer (NSCLC) without driver mutations — and what it means for clinicians on the front lines of care. We're drawing on a conversation with Dr. Joshua Reuss, thoracic medical oncologist at Georgetown University and co-chair of ASCO's Living Guidance Committee, who helped explain the ke...
13m • Mar 11
13m
S7 Ep8: Precision Hope: The New Frontier of AI-Driven Oncology
Host Pallav Mehta, MD, and guest Doug Flora, MD discuss the use of artificial intelligence (AI) in oncology. As the author of Rebooting Cancer Care, Flora argues that AI is the essential "reboot" needed for a system currently "groaning under its own weight" due to physician burnout and an unmanageable explosion of medical data.
36m • Mar 04
36m
S7 Ep7: Community Oncology at a Crossroads: Navigating Policy, Progress, and Practice
In this episode of Treating Together, host Pallav Mehta, MD, medical oncologist and director of Integrative Oncology at Cooper University Health Care and medical director of Reimagine Care, is joined by Debra Patt, MD, PhD, MBA, oncologist and executive vice president at Texas Oncology. Patt also serves as the president of the Community Oncology Alliance (COA). Their discussion focuses on the r...
44m • Feb 18
44m
S7 Ep6: Navigating the Future of CLL Care
In this episode of Treating Together, host Marc Braunstein, MD, an associate professor of medicine at the Perlmutter Cancer Center, NYU Grossman School of Medicine, is joined by John Burke, MD, from Rocky Mountain Cancer Centers. Both specialists bring their extensive experience in lymphoma and multiple myeloma to a deep-dive discussion on the rapidly evolving treatment landscape of chronic lym...
17m • Feb 04
17m
S7 Ep5: Supporting Community Oncologists in a GU Research Era with Dr. Park, Dr. Garmezy, and Dr. Bupathi
This episode of Treating Together, hosted by Chandler Park, MD, featuring guests Benjamin Garmezy, MD, and Manoj Bupathi, MD,  centers on the intersection of clinical research and community oncology, specifically within the field of genitourinary (GU) oncology. Core Themes and Discussion Points The Community Oncology Gap: Park highlights a critical statistic: 80% to 85% of patients with cance...
27m • Jan 21
27m
S7 Ep4: Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD
7m • Dec 15, 2025
7m
S7 Ep3: Experts Delve Into Organ Preservation for Genitourinary Cancers
Benjamin Garmezy, MD, and Alexander Kenigsberg, MD, discuss strategies for preserving organs in GU cancers in the Treating Together podcast.
26m • Oct 31, 2025
26m
S7 Ep2: Navigating Modern Lung Cancer Treatment and Clinical Trial Access
Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss advancing lung cancer care and tackling real-world access barriers for community physicians.
23m • Sep 29, 2025
23m
S7 Ep1: Advancing Prostate Cancer Treatment With Shared Decision-Making
In our first episode of Treating Together, Benjamin Garmezy, MD, and Ralph J. Miller Jr, MD, discuss multidisciplinary prostate cancer care.
25m • Jul 31, 2025
25m
S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning
Xiaojie Zhang, MD, and Akshat Singhal, PhD, discuss their research leveraging deep learning to predict how patients with ER+/HER2- breast cancer will respond to palbociclib.
37m • Apr 15, 2025
37m
S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall
In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.
15m • Mar 13, 2025
15m
S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain
David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology and the many advancements shaping lymphoma treatment today.
28m • Feb 27, 2025
28m
S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan (https://www.targetedonc.com/view/fda-approves-dato-dxd-in-hr-her2-breast-cancer) for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.
8m • Feb 06, 2025
8m
S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment
In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting advancements of artificial intelligence in 2024, specifically focusing on its transformative impact on early cancer detection.
35m • Jan 15, 2025
35m
S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research
In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.
16m • Nov 14, 2024
16m
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.
28m • Oct 31, 2024
28m
S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology
Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.
16m • Oct 17, 2024
16m
S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer
In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD...
14m • Sep 26, 2024
14m
S5 Ep16: Foran Goes Beyond the Basics of BPDCN
In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.
23m • Sep 17, 2024
23m
S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates
In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.
31m • Aug 30, 2024
31m
S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel
In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.
16m • Aug 15, 2024
16m
S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US
In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and oncology.
19m • Aug 01, 2024
19m
S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role
In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.
18m • Jul 15, 2024
18m
S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine
Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.
24m • Jul 01, 2024
24m
S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM
In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.
20m • Jun 14, 2024
20m
S5 Ep9: Unlocking the Potential of Technology in Community Oncology
In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting.
26m • May 15, 2024
26m
S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology
In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.
14m • May 01, 2024
14m
S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches
In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testi...
27m • Apr 15, 2024
27m
S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding
In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.
19m • Apr 01, 2024
19m
S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC
In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.
23m • Mar 15, 2024
23m
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC
In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.
19m • Mar 01, 2024
19m
S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing
In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.
22m • Feb 15, 2024
22m
S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC
In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.
20m • Feb 01, 2024
20m
S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer
In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.
24m • Jan 15, 2024
24m
S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care
In this episode of Targeted Talks, Aaron Lisberg, MD, discusses results from the phase 3 TROPION-Lung01 study of datopotamab c in advanced or metastatic non–small cell lung cancer.
16m • Dec 15, 2023
16m
S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities
In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities.
16m • Nov 30, 2023
16m
S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC
In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.
9m • Nov 15, 2023
9m
S4 Ep17: Bridging Science and Compassion in Cancer Care
In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.
20m • Oct 31, 2023
20m
S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer
In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.
26m • Oct 13, 2023
26m
S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field
In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.
12m • Sep 29, 2023
12m

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.